v3.26.1
Nature of Operations, Basis of Presentation, and Liquidity (Details)
6 Months Ended
Apr. 29, 2025
$ / shares
Oct. 01, 2024
USD ($)
Jan. 18, 2022
USD ($)
Jun. 30, 2026
USD ($)
D
$ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Apr. 10, 2025
shares
Apr. 09, 2025
shares
Mar. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Nature of Operations, Basis of Presentation, and Liquidity                  
Reverse stock split ratio 0.04                
Common stock, par value (in dollars per share) | $ / shares $ 0.0001     $ 0.0001 $ 0.0001        
Common Stock, Shares Authorized | shares       7,000,000,000 250,000,000 7,000,000,000 250,000,000    
Cash and cash equivalents       $ 3,488,595 $ 5,136,722        
Working capital       (700,000)          
Accumulated deficit       $ 113,237,437 $ 111,294,776        
Regulatory approvals in metuchen affiliates | D       30          
ABC Assets                  
Nature of Operations, Basis of Presentation, and Liquidity                  
Liquidation fees agreed to pay               $ 60,000  
Liquidation cash fee payable               9.00%  
Notes payable                  
Nature of Operations, Basis of Presentation, and Liquidity                  
Principal amount of notes payable     $ 10,201,758            
Payment due pursuant to the note and security agreement   $ 500,000              
Principal balance                 $ 7,574,824
Foreclosed collateral       $ 2,000,000          
Vivus, Inc                  
Nature of Operations, Basis of Presentation, and Liquidity                  
Purchase of obligation     12,400,000            
Purchase commitments     4,250,000            
Vivus, Inc | Settlement Agreement                  
Nature of Operations, Basis of Presentation, and Liquidity                  
Inventory amount retained - API     7,300,000            
Payment made for purchase order     $ 1,542,904            
Percentage of stendra tablets released     50            
Vivus, Inc | Settlement Agreement | Promissory Note                  
Nature of Operations, Basis of Presentation, and Liquidity                  
Prepayment amount     $ 900,000